It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2019.
2019 | Hyderabad, Telangana, India | ActiveOmnicrux Life Sciences Private Limited, a active private limited company, was established on 24 October 2019 in Hyderabad, Telangana, India. Engaging in pharma contract r&d within the pharma sector, it holds CIN: U24232TG2019PTC136330. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Madhavi Varalwar (Director), Rohit Dansingh Negi (Director), Annakulam Vivekanandan (Director). Past directors included Ramesh Krishnamurthy, Rohit Dansingh Negi, Varalwar Manas. Its latest AGM occurred on 27 September 2025, with the balance sheet filed on 31 March 2025. It is based at 450 Alexandria Knowledge Park Turkapally, Hyderabad Ranga Red, Hyderabad, Telangana, 500078.
U24232TG2019PTC136330
136330
24 October 2019
₹0.10 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Omnicrux Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Madhavi Varalwar | Director | 24 Oct 2019 | Current |
| Rohit Dansingh Negi | Director | 01 Dec 2023 | Current |
| Annakulam Vivekanandan | Director | 02 Sep 2022 | Current |
| Anurag Bhoop Narayan Pathak | Director | 01 Dec 2023 | Current |
| Anil Kashiram Fokmare | Additional Director | 14 Jun 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 13 Nov 2021 | Past |
| Pramod Abcsdd | Additional Director | 26 Sep 2022 | Past |
| Pramod Abcsdd | Director | 09 Oct 2020 | Past |
| Pramod Abcsdd | Additional Director | 02 May 2023 | Past |
| Pramod Abcsdd | Additional Director | 26 Sep 2022 | Past |
| Pramod Abcsdd | Additional Director | 27 Sep 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Omnicrux Life Sciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Omnicrux Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Omnicrux Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Omnicrux Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Omnicrux Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Omnicrux Life Sciences Private Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records. was documented.
The activity Anil Kashiram Fokmare was appointed as a Additional Director was appointed as a Additional Director on 14 Jun 2025 & has been associated with this company since 5 months 16 days . was completed.
Omnicrux Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was recorded as a recent event.
The activity Rohit Dansingh Negi was appointed as a Director was appointed as a Director on 01 Dec 2023 & has been associated with this company since 1 year 11 months . was completed.
Progress on Anurag Bhoop Narayan Pathak was appointed as a Director was appointed as a Director on 01 Dec 2023 & has been associated with this company since 1 year 11 months . was documented.
Annakulam Vivekanandan was appointed as a Director was appointed as a Director on 02 Sep 2022 & has been associated with this company since 3 years 2 months . was recorded as a recent event.
The CIN of Omnicrux Life Sciences Private Limited is U24232TG2019PTC136330.
Omnicrux Life Sciences Private Limited is headquartered at 450 Alexandria Knowledge Park Turkapally, Hyderabad Ranga Red, Hyderabad, Telangana, 500078.
Omnicrux Life Sciences Private Limited was incorporated on 24 October 2019.
The current directors of Omnicrux Life Sciences Private Limited are
The primary industry of Omnicrux Life Sciences Private Limited is Pharma.
Omnicrux Life Sciences Private Limited is unlisted.
The authorized capital of Omnicrux Life Sciences Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX